Page last updated: 2024-10-23

azathioprine and Gastroparesis

azathioprine has been researched along with Gastroparesis in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Gastroparesis: Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kristinsson, JO1
Hopman, WP1
Oyen, WJ1
Drenth, JP1

Other Studies

1 other study available for azathioprine and Gastroparesis

ArticleYear
Gastroparesis in patients with inactive Crohn's disease: a case series.
    BMC gastroenterology, 2007, Mar-21, Volume: 7

    Topics: Adrenal Cortex Hormones; Adult; Antimetabolites; Azathioprine; Crohn Disease; Drug Therapy, Combinat

2007